Readnour Robin Shane: insider trades.
Readnour Robin Shane reported 8 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 8 sales ($317K), across 1 company.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 8
- Companies
- 1
- Name as filed
- Readnour Robin Shane
Companies
| Company | Relationship | Transactions |
|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | Director | 8 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-09 | AN2 Therapeutics, Inc. | S | 585 | $6.02 | 624,765 | Form 4 |
| 2026-09-09 | AN2 Therapeutics, Inc. | S | 523 | $6.02 | 557,467 | Form 4 |
| 2026-09-08 | AN2 Therapeutics, Inc. | S | 4,725 | $6.02 | 557,990 | Form 4 |
| 2026-09-08 | AN2 Therapeutics, Inc. | S | 5,294 | $6.02 | 625,350 | Form 4 |
| 2026-09-03 | AN2 Therapeutics, Inc. | S | 2,877 | $6.07 | 562,715 | Form 4 |
| 2026-09-03 | AN2 Therapeutics, Inc. | S | 3,223 | $6.07 | 630,644 | Form 4 |
| 2026-08-17 | AN2 Therapeutics, Inc. | S | 16,696 | $6.01 | 565,592 | Form 4 |
| 2026-08-17 | AN2 Therapeutics, Inc. | S | 18,706 | $6.01 | 633,867 | Form 4 |
Questions
What stock did Readnour Robin Shane buy or sell?
Readnour Robin Shane reported 8 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 8 sales ($317K), across 1 company.
Is Readnour Robin Shane the same person as other filers with this name?
This page covers SEC CIK 1914883 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/readnour-robin-shane-1914883.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.